Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance. (2015)
Attributed to:
Expansion of MRCTs Drug Discovery Group (DDG)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.dnarep.2015.04.002
PubMed Identifier: 25956741
Publication URI: http://europepmc.org/abstract/MED/25956741
Type: Journal Article/Review
Volume: 31
Parent Publication: DNA repair
ISSN: 1568-7856